Cargando…
Early growth response-1: Key mediators of cell death and novel targets for cardiovascular disease therapy
SIGNIFICANCE: Cardiovascular diseases are seen to be a primary cause of death, and their prevalence has significantly increased across the globe in the past few years. Several studies have shown that cell death is closely linked to the pathogenesis of cardiovascular diseases. Furthermore, many molec...
Autores principales: | Xie, Yixin, Li, Yongnan, Chen, Jianshu, Ding, Hong, Zhang, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086247/ https://www.ncbi.nlm.nih.gov/pubmed/37057102 http://dx.doi.org/10.3389/fcvm.2023.1162662 |
Ejemplares similares
-
Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022) -
Metal-Binding Proteins Cross-Linking with Endoplasmic Reticulum Stress in Cardiovascular Diseases
por: Li, Kejuan, et al.
Publicado: (2023) -
Editorial: Cytokines, novel cell death models and pathways in cardiovascular diseases
por: Cai, Yang-Wei, et al.
Publicado: (2023) -
Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022) -
Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022)